Pantogar capsules blister No. 90

Instructions for use Pantogar capsules blister No. 90

Composition

active ingredients: medical yeast, calcium pantothenate, thiamine nitrate, cystine, keratin, 4-aminobenzoic acid;

1 capsule contains: medical yeast 100 mg; calcium pantothenate 60 mg; thiamine nitrate 60 mg; cystine 20 mg; keratin 20 mg; 4-aminobenzoic acid 20 mg;

Excipients: microcrystalline cellulose, povidone, colloidal anhydrous silica, talc, magnesium stearate, gelatin, titanium dioxide (E 171), yellow iron oxide (E 172), indigo carmine (E 132).

Dosage form

Capsules.

Main physicochemical properties: hard gelatin capsules size 1 with a dark green opaque cap and an ivory opaque body; capsule contents are a fine beige-brown powder with a faint yeast odor.

Pharmacotherapeutic group

Combined vitamin preparations. ATX code: A11J C.

Pharmacological properties

Pharmacodynamics.

The active ingredients of the drug belong to the following therapeutic groups: vitamins, nutritional supplements, amino acids, proteins.

Thiamine nitrate, calcium pantothenate, and other vitamins contained in medical yeast are necessary to maintain optimal metabolic regulation in the body.

Insufficient intake of these vitamins by the body leads to deficiency symptoms.

Keratin is the main component of hair and nails, cystine and 4-aminobenzoic acid are also substances that strengthen hair and nails.

Pantogar reduces hair loss caused by various causes, improving the hair structure and increasing its resistance to mechanical and chemical damage. Pantogar promotes nail growth and increases their strength.

Pharmacokinetics.

Pharmacokinetic studies of Pantogar have not been conducted. Vitamins are absorbed in the upper gastrointestinal tract. Amino acid components obtained as a result of keratin hydrolysis (L-cystine and 4-aminobenzoic acid) are absorbed by passive diffusion and/or through certain transport systems.

Indication

Diffuse hair loss (hair loss for unknown reasons).

Degenerative changes in hair structure (thin, hard, brittle, lifeless, dull, colorless hair).

Hair damaged by sunlight or UV radiation.

Prevention of gray hair.

Nail growth disorders (brittleness, delamination, inflexibility).

Contraindication

Hypersensitivity to any component of the drug.

Interaction with other medicinal products and other types of interactions

When using drugs containing sulfonamide at the same time, you should consult a doctor.

Use during pregnancy or breastfeeding

Animal studies are insufficient to indicate effects on pregnancy and embryonal/fetal development, child development and postnatal development. No risk to humans is known. During pregnancy and lactation, Pantogar should be prescribed only after careful assessment of the benefit and possible risk ratio.

Ability to influence reaction speed when driving vehicles or other mechanisms

Does not affect.

Method of administration and doses

Used internally.

The drug should be taken during meals, without chewing, with sufficient liquid.

Adults should take 1 capsule 3 times a day, children over 12 years old should take 1-2 capsules once a day.

The average duration of treatment is 3-6 months. If necessary, the course of treatment can be extended or repeated.

Children

Due to the lack of sufficient experience in younger children, the drug should not be used in children under 12 years of age.

Overdose

Symptoms of overdose are not known.

Side effects

The adverse reactions listed below are classified by system organ class and frequency. The frequency categories are: very common ≥ 1/10, common ≥ 1/100 and < 1/10, uncommon ≥ 1/1000 and < 1/100, rare ≥ 1/10000 and < 1/1000, very rare < 1/10000, or not known if the frequency cannot be estimated from the available data.

Nervous system disorders

Frequency unknown: headache and dizziness.

Cardiovascular disorders

Rare: tachycardia, rapid pulse.

Frequency unknown: rapid heartbeat (palpitations).

Gastrointestinal disorders

Frequency unknown: nausea, vomiting, abdominal pain, flatulence, heartburn, diarrhea.

Skin and skin-related disorders

Rare: urticaria, rash, itching.

Frequency unknown: skin redness.

Immune system disorders:

Rare: hypersensitivity reactions such as increased sweating.

If any adverse reactions occur, discontinue use of the drug and consult a doctor.

Expiration date

3 years.

Do not use the drug after the expiration date indicated on the package.

Storage conditions

Store at a temperature not exceeding 25 ° C. Keep out of the reach of children.

Packaging

15 capsules in a blister, 6 blisters in a cardboard box.

Vacation category

Without a prescription.

Producer

Acino Pharma AG/ Acino Pharma AG.

Location of the manufacturer and address of its place of business.

Birsweg 2, 4253 Liesberg, Switzerland.